诊室血管溶解激光联合或不联合息肉切除术治疗声带息肉的疗效与不良事件
回顾性队列研究纳入97例声带息肉患者,在诊室接受532nm血管溶解激光治疗,其中30%仅激光,70%联合息肉切除。两种方式均显著改善嗓音,联合息肉切除组不良事件更少(3% vs 21%),需再次治疗者更少(1% vs 21%)。
要点
- 诊室血管溶解激光是声带息肉的有效替代治疗。
- 联合息肉切除可减少不良事件及再次治疗需求。
- 术后不良事件多为轻度,包括声带水肿、血肿和溃疡。
核心结论
- 诊室血管溶解激光治疗声带息肉有效,但可能需多次治疗并偶发轻度不良事件。
- 激光凝血后联合息肉切除可减少激光能量释放,降低术后不良事件风险及额外治疗需求。
研究设计与样本
- 回顾性队列研究,纳入97例连续声带息肉患者,2014年1月1日至2016年8月31日在三级医疗中心接受诊室532nm激光治疗。
- 排除17例数据缺失或不完整者,最终97例纳入分析。
主要发现
- 97例患者平均年龄45.6(11.3)岁,男性48例(49%),症状平均持续时间10.1个月(范围1-60个月)。
- 联合息肉切除组仅1例(1%)需再次治疗,显著少于单纯激光组的6例(21%)(效应量-1.57;95%CI -2.77至-0.36)。
- 共8例(8%)出现不良事件:声带水肿5例、声带血肿2例、声带溃疡1例。
- 联合息肉切除组不良事件显著少于单纯激光组(2例[3%] vs 6例[21%];效应量1.20;95%CI 0.26至2.13)。
临床怎么用
- 诊室血管溶解激光可作为声带息肉的治疗选择,联合息肉切除可能减少不良事件和再次治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In-office angiolytic laser procedures have been used successfully as an alternative treatment for vocal fold polyps; little is known in detail about the treatment outcomes and adverse events. OBJECTIVE: To examine the outcomes and incidence rates of adverse events associated with in-office angiolytic laser procedures with or without concurrent polypectomy as an alternative treatment for vocal fold polyps. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study at a tertiary medical center. We identified 114 consecutive patients with vocal polyps who underwent in-office angiolytic laser treatments between January 1, 2014, and August 31, 2016. After the exclusion of 17 with missing or incomplete data, 97 were enrolled. INTERVENTIONS: In-office 532-nm laser procedures with or without concurrent polypectomy. MAIN OUTCOMES AND MEASURES: Between 1 and 2 months after the surgical procedures, we collected the following outcome data: videolaryngostroboscopy, perceptual rating of voice quality, acoustic analysis, maximal phonation time, and subjective rating of voice quality using a visual analogue scale and 10-item voice handicap index. RESULTS: This study enrolled 97 patients (mean [SD] age, 45.6 [11.3] years; 48 [49%] male). The mean duration of symptoms was 10.1 months (range, 1-60 months). Twenty-nine patients (30%) had angiolytic laser procedures only, while 68 (70%) received laser with concurrent polypectomy. Both treatment modalities offered significant improvements. Only 1 patient (1%) receiving angiolytic laser with concurrent polypectomy underwent another treatment session, so this group had significantly less need for multiple treatments than those receiving laser treatment alone (6 [21%]; effect size, -1.57; 95% CI, -2.77 to -0.36). We identified 8 adverse events (8% of the cases): vocal fold edema (n = 5), vocal hematoma (n = 2), and vocal ulceration (n = 1). Patients treated with laser plus concurrent polypectomy had significantly fewer adverse events than those treated with angiolytic laser alone (2 [3%] vs 6 [21%]; effect size, 1.20; 95% CI, 0.26 to 2.13). CONCLUSIONS AND RELEVANCE: In-office angiolytic laser procedures can be an effective alternative treatment for vocal polyps, although with possible need for multiple treatment sessions and occasional occurrence of minor postoperative adverse events. Concurrent polypectomy following laser coagulation allows less laser energy delivery and reduces the risk of postoperative adverse events and the need for additional treatment sessions.
引用
- Lin YH, Wang CT, Lin FC, et al. Treatment Outcomes and Adverse Events Following In-Office Angiolytic Laser With or Without Concurrent Polypectomy for Vocal Fold Polyps. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29346486. doi:10.1001/jamaoto.2017.2899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。